Literature DB >> 17668279

Comparison of the dynamics and correlates of transmission of Herpes Simplex Virus-1 (HSV-1) and Varicella-Zoster Virus (VZV) in a sample of the Israeli population.

Batya B Davidovici1, Ran D Balicer, Eyal Klement, Manfred S Green, Ella Mendelson, Zehava Smetana, Dani I Cohen.   

Abstract

Herpes simplex virus types-1 (HSV-1) and Varicella-zoster virus (VZV) are herpes viruses that share many characteristics. However, HSV-1 spreads by close contact while VZV spreads mainly by the airborne route. In this study we compared the dynamics and correlates of transmission of these viruses in the same population. In 2000-2001, 1555 sera from an age-stratified general population sample were tested using commercial ELISA kits to measure type-specific HSV-1 and varicella IgG antibodies. The VZV seroprevalence increased rapidly with age reaching 50% seropositivity by the age of 3 years, while HSV-1 reached 50% seropositivity at the age of 14 years. The highest VZV force of infection was in the 3.5-5.5-year age group followed by the 5.5-10.5 years age group, while for HSV-1 the age specific force of infection was substantially lower and stable over the various age groups. Multivariate analysis revealed that HSV-1 seroprevalence was significantly, independently associated with age, country of birth, country of origin, ethnicity, socio-economic status and VZV sero-status. Only age, country of origin and HSV-1 sero-status were found to be associated with VZV seropositivity. In developed countries such as Israel the transmission of VZV is much quicker and less dependent on socioeconomic status as compared with HSV-1.

Entities:  

Mesh:

Year:  2007        PMID: 17668279     DOI: 10.1007/s10654-007-9169-3

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  23 in total

1.  Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps).

Authors:  R E H SIMPSON
Journal:  Lancet       Date:  1952-09-20       Impact factor: 79.321

2.  Modification of chicken pox in family contacts by administration of gamma globulin.

Authors:  A H ROSS
Journal:  N Engl J Med       Date:  1962-08-23       Impact factor: 91.245

3.  Varicella vaccine studies in healthy children and adults.

Authors:  A M Arbeter; S E Starr; S A Plotkin
Journal:  Pediatrics       Date:  1986-10       Impact factor: 7.124

4.  Seroepidemiological study of herpes viruses in Nepal.

Authors:  T Kubo; S K Rai; M Nakanishi; T Yamano
Journal:  Southeast Asian J Trop Med Public Health       Date:  1991-09       Impact factor: 0.267

5.  Seroprevalence of herpes simplex virus 1 and 2 and correlates of infection in Israel.

Authors:  Batya B Davidovici; Manfred Green; Mehran J Marouni; Ravit Bassal; Jeanne M Pimenta; Dani Cohen
Journal:  J Infect       Date:  2005-10-06       Impact factor: 6.072

6.  Seroprevalence and force of infection of varicella-zoster virus in Luxembourg.

Authors:  J Mossong; L Putz; F Schneider
Journal:  Epidemiol Infect       Date:  2004-12       Impact factor: 2.451

Review 7.  Performance and use of HSV type-specific serology test kits.

Authors:  Rhoda L Ashley
Journal:  Herpes       Date:  2002-07

8.  Development of antibodies against cytomegalovirus, varicella-zoster virus and herpes simplex virus in Finland during the first eight years of life: a prospective study.

Authors:  Johanna Aarnisalo; Jorma Ilonen; Raija Vainionpää; Iina Volanen; Tuuli Kaitosaari; Olli Simell
Journal:  Scand J Infect Dis       Date:  2003

9.  Antibody to Varicella-Zoster virus in parturient women and their offspring during the first year of life.

Authors:  A A Gershon; R Raker; S Steinberg; B Topf-Olstein; L M Drusin
Journal:  Pediatrics       Date:  1976-11       Impact factor: 7.124

10.  Longitudinal risk of herpes simplex virus (HSV) type 1, HSV type 2, and cytomegalovirus infections among young adolescent girls.

Authors:  Lawrence R Stanberry; Susan L Rosenthal; Lisa Mills; Paul A Succop; Frank M Biro; Rhoda Ashley Morrow; David I Bernstein
Journal:  Clin Infect Dis       Date:  2004-10-25       Impact factor: 9.079

View more
  3 in total

1.  Recent trends in publications in the European Journal of Epidemiology.

Authors:  Albert Hofman
Journal:  Eur J Epidemiol       Date:  2008       Impact factor: 8.082

2.  Toxoplasma gondii seropositivity and co-infection with TORCH pathogens in high-risk patients from Qatar.

Authors:  Marawan A Abu-Madi; Jerzy M Behnke; Haydee A Dabritz
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

3.  Covid-19 Pandemic: What Changes for Dentists and Oral Medicine Experts? A Narrative Review and Novel Approaches to Infection Containment.

Authors:  Maria Eleonora Bizzoca; Giuseppina Campisi; Lorenzo Lo Muzio
Journal:  Int J Environ Res Public Health       Date:  2020-05-27       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.